Education
About Us
Working with TipRanks
Follow Us
David Raymond Ebsworth Insider Profile
4 Followers
David Raymond Ebsworth, Director at Verona Pharma, holds 86.98K shares in Verona Pharma (Ticker: GB:VRP), holds 105.58K shares in Verona Pharma (Ticker: VRNA), holds ― shares in Sartorius (Ticker: GB:0NIQ). Most recently, David Raymond Ebsworth ― shares of Verona Pharma on ― for an estimated value of ―.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+0.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
David Raymond Ebsworth does not currently own shares as a corporate insider.
A breakdown of David Raymond Ebsworth's holdings
Insider Roles
Roles that David Raymond Ebsworth holds in companies
Most Profitable Insider Trade
Stock:
SYNLAB AG
(SYAB)
(SYAB)
Rating:Informative Sell
Date:Apr 30, 2021 - Apr 30, 2022
Return:+26.20%
The most profitable trade made by David Raymond Ebsworth
David Raymond Ebsworth's Trading History
Verona Pharma
―
―
―
£47.84K
Verona Pharma
―
―
―
$11.29M
Heidelberg Pharma AG
Nov 30, 2009
Director
Informative Buy
41.00K
―
SYNLAB AG
Apr 19, 2024
―
Informative Sell
489.14K
―
Sartorius
Feb 13, 2026
Director
Informative Buy
170.68K
―
List of latest transactions for each holding click on a transaction to see David Raymond Ebsworth's performance on stock
You May Also Like
David Raymond Ebsworth insider profile FAQ
What is the percentage of profitable transactions made by David Raymond Ebsworth?
The percentage of profitable transactions made by David Raymond Ebsworth is 50%.
What is the average return per transaction made by David Raymond Ebsworth?
The average return per transaction made by David Raymond Ebsworth is 0.20%.
What stocks does David Raymond Ebsworth hold?
David Raymond Ebsworth holds: GB:VRP, VRNA, GB:0QW5, DE:SYAB, GB:0NIQ stocks.
What was David Raymond Ebsworth’s latest transaction?
David Raymond Ebsworth latest transaction was an Uninformative Buy of ―.
What was David Raymond Ebsworth's most profitable transaction?
David Raymond Ebsworth’s most profitable transaction was an Informative Sell of DE:SYAB stock on April 30, 2021. The return on the trade was 26.20%.
What is David Raymond Ebsworth's role in Verona Pharma?
David Raymond Ebsworth's role in Verona Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.